Precision Medicine & Health Equity
Immunotherapy in Cancer
September 23, 2016 in Atlanta, GA | #PrecisionMedicine
Derrick J. Beech, M.D., FACS
Throughout his medical training, Dr. Beech gravitated towards the field of oncology. In 1993, he completed his fellowship training in Surgical Oncology at University of Texas MD Anderson Cancer Center. Since completing his fellowship, Dr. Beech has devoted his time to treating patients, as well as cultivating competent future physicians. Dr. Beech served as the Chief of Surgery at Meharry Medical College, in Nashville, Tennessee. He currently works at Grady Memorial Hospital, performing a wide array of surgical oncological procedures.
In the Plenary Session IV, Dr. Beech will discuss Color Genomics and Hereditary Disease: Representing Contributions of the HeLa Cell Legacy.
Sharad A. Ghamande, MD
Dr. Ghamande completed his Fellowship in Gynecologic Oncology at Roswell Park Cancer Institute in Buffalo, New York in 2000. He also completed Fellowship programs at both Memorial Sloan Kettering Cancer Center and M.D. Anderson. His Residency in Obstetrics and Gynecology was completed at Boston Medical Center in Boston, Massachusetts. He is board certified in both Obstetrics and Gynecology and Gynecologic Oncology.
In the Plenary Session I, Dr. Ghamande will discuss Recent Advances in Immunotherapy: Treatment of Cervical Cancer.
David H. Lawson, MD
Roland A. Pattillo Lecturer
A medical oncologist, David H. Lawson, MD, leads a melanoma program that incorporates the best of basic and clinical science with the goal of improving the care of patients with melanoma. To that end, he has established an active melanoma working group. The group funds seed grants for basic or clinical research, and also participates in and leads clinical trials at all phases of therapy development.
In the Plenary Session III, Dr. Lawson will discuss Immunotherapy Success in Brain Metastatic Melanoma.
Chandrika J. Piyathilake, PhD
Dr. Piyathilake is a Professor of Nutritional Biochemistry and Genomics, Department of Nutrition Sciences, University of Alabama at Birmingham (UAB) and a Scientist of the UAB's NIH-funded Clinical Nutrition Research Center (CNRC), Comprehensive Cancer Center (CCC) and the Minority Health Research Center (MHRC). Her post doctoral training was focused on diet and cancer prevention with a special interest in nutrient-related intermediate endpoint biomarkers of cancer. Her research goals are to systematically develop promising dietary interventions for cancer prevention while understanding the underlying molecular mechanisms of action.
In the Plenary Session II, Dr. Piyathilake will discuss Prevention & Control of HPV Related Cancers.